Primary role of growth-related oncogene-α and granulocyte chemotactic protein-2 as neutrophil chemoattractants in chronic rhinosinusitis

Clinical and Experimental Allergy

Volumn 36, Issue 6, 2006, Pages 748-759

  Rudack, C ^a   Sachse, F ^a   Alberty, J ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Chemokines; Chronic rhinosinusitis; Epithelium; Growth related oncogene (GRO ); Neutrophils

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CHEMOTACTIC FACTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GROWTH RELATED ONCOGENE ALPHA; INTERLEUKIN 8; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC DISEASE; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NUCLEOTIDE SEQUENCE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHINOSINUSITIS;

ADULT; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; MALE; NASAL MUCOSA; NEUTROPHIL ACTIVATION; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS; SINUSITIS;

EID: 33745656442     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2006.02501.x     Document Type: Article

References (26)

1. Meltzer EO, Hamilos DL, Hadley JA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004; 131:S1-62.
2. Fokkens W, Lund V, Bachert C et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005; 60:583-601.
3. Bachert C, Hormann K, Mosges R et al. An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy 2003; 58:176-91.
4. Stankiewicz JA, Chow JM. Nasal endoscopy and the definition and diagnosis of chronic rhinosinusitis. Otolaryngol Head Neck Surg 2002; 126:623-7.
5. Schlosser RJ, Spotnitz WD, Peters EJ, Fang K, Gaston B, Gross CW. Elevated nitric oxide metabolite levels in chronic sinusitis. Otolaryngol Head Neck Surg 2000; 123:357-62.
6. Atsuta S, Majima Y. Nasal mucociliary clearance of chronic sinusitis in relation to rheological properties of nasal mucus. Ann Otol Rhinol Laryngol 2000; 107:47-51.
7. Braverman I, Wright ED, Wang CG, Eidelman D, Frenkiel S. Human nasal ciliary-beat frequency in normal and chronic sinusitis subjects 182. J Otolaryngol 1998; 27:145-52.
8. Lindberg S, Cervin A, Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol 1997; 117:113-7.
9. Benninger MS, Ferguson BJ, Hadley JA et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003; 129:S1-32.
10. Van Cauwenberge P, Watelet JB. Epidemiology of chronic rhinosinusitis. Thorax 2000; 55 Suppl. 2:S20-S1.
11. Wuyts A, Proost P, Lenaerts JP, Ben Baruch A, Van Damme J, Wang JM. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Eur J Biochem 1998; 255:67-73.
12. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15:675-705.
13. Mantovani A. Inflammatory cytokines. Recenti Prog Med 2000; 91:422-4.
14. Luster AD, Cardiff RD, MacLean JA, Crowe K, Granstein RD. Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc Assoc Am Physicians 1998; 110:183-96.
15. Luster AD. Mechanisms of disease: chemokines - chemotactic cytokines that mediate inflammation [Article]. N Engl J Med 1998; 338:436-45.
16. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12:121-7.
17. Rudack C, Hermann W, Eble J, Schroeder JM. Neutrophil chemokines in cultured nasal fibroblasts. Allergy 2002; 57:1159-64.
18. Rudack C, Jorg S, Sachse F. Biologically active neutrophil chemokine pattern in tonsillitis. Clin Exp Immunol 2004; 135:511-8.
19. Rudack C, Maune S, Eble J, Schroeder JM. The primary role in biologic activity of the neutrophil chemokines IL-8 and GRO-alpha in cultured nasal epithelial cells. J Interferon Cytokine Res 2003; 23:113-23.
20. Rudack C, Prehm P, Stoll W, Maune S. Extracellular matrix components in nasal polyposis. Acta Otolaryngol 2003; 123:643-7.
21. Rudack C, Sachse F, Alberty J. Chronic rhinosinusitis-need for further classification? Inflamm Res 2004; 53:111-7.
22. Rudack C, Stoll W, Bachert C. Cytokines in nasal polyposis, acute and chronic sinusitis. Am J Rhinol 1998; 12:383-8.
23. Schroder JM. Identification and structural characterization of chemokines in lesional skin material of patients with inflammatory skin disease. Methods Enzymol 1997; 288:266-97.
24. Klein AM, Anderson K, Lafreniere D, Leonard G, Kreutzer D. Growth-related oncogene-alpha expression in human nasal polyps. Otolaryngol Head Neck Surg 2000; 123:85-90.
25. Wuyts A, Struyf S, Gijsbers K et al. The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8. Lab Invest 2003; 83:23-34.
26. Gijsbers K, Van Assche G, Joossens S et al. CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue. Eur J Immunol 2004; 34:1992-2000.